We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

45 hedge funds and large institutions have $4.24M invested in Ampio Pharmaceuticals Inc. in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more call options, than puts

Call options by funds: $35K | Put options by funds: $30K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

7% less capital invested

Capital invested by funds: $4.55M → $4.24M (-$305K)

20% less funds holding

Funds holding: 56 → 45 (-11)

71% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 14

Holders
45
Holders Change
-11
Holders Change %
-19.64%
% of All Funds
1.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
7
Reduced
7
Closed
14
Calls
$35K
Puts
$30K
Net Calls
+$5K
Net Calls Change
-$20K

Top Buyers

Rank Fund Capital Flow
1
UCFA
United Capital Financial Advisors
Texas
+$8.07K
2
AG
Advisor Group
Arizona
+$7.44K
3
Wolverine Trading
Wolverine Trading
Illinois
+$6.33K
4
BlackRock
BlackRock
New York
+$6.02K
5
VF
Virtu Financial
New York
+$5.54K

Top Sellers

Rank Fund Capital Flow
1
Legal & General Group
Legal & General Group
United Kingdom
-$170K
2
ECM
Element Capital Management
New York
-$151K
3
Goldman Sachs
Goldman Sachs
New York
-$148K
4
PP
Paloma Partners
Connecticut
-$94K
5
LP
LMR Partners
United Kingdom
-$82K
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Knoll Capital Management
Florida
$1.61M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$799K -$72.4K -457 -9%
BlackRock
3
BlackRock
New York
$749K +$6.02K +38 +0.9%
Millennium Management
4
Millennium Management
New York
$217K -$56.4K -356 -23%
NFG
5
Noven Financial Group
Colorado
$150K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$147K -$1.27K -8 -1%
TW
7
Transform Wealth
Colorado
$86K – – –
GIA
8
GHP Investment Advisors
Colorado
$61K – – –
Northern Trust
9
Northern Trust
Illinois
$53K – – –
CCMW
10
Cypress Capital Management (Wyoming)
Wyoming
$44K – – –
AG
11
Advisor Group
Arizona
$30K +$7.44K +47 +39%
Group One Trading
12
Group One Trading
Illinois
$29K -$5.7K -36 -18%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$25K +$1.74K +11 +9%
BJL
14
Brighton Jones LLC
Washington
$19K – – –
State Street
15
State Street
Massachusetts
$16K – – –
GC
16
Guggenheim Capital
Illinois
$14K – – –
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$13K – – –
OWP
18
Obermeyer Wealth Partners
Colorado
$12K – – –
OC
19
Oppenheimer & Co
New York
$12K – – –
Wells Fargo
20
Wells Fargo
California
$12K +$317 +2 +3%
Citadel Advisors
21
Citadel Advisors
Florida
$11K -$12.5K -79 -56%
JWA
22
JFS Wealth Advisors
Pennsylvania
$11K – – –
LTFS
23
Ladenburg Thalmann Financial Services
Florida
$11K +$317 +2 +3%
Brown Advisory
24
Brown Advisory
Maryland
$10K – – –
JWM
25
Janiczek Wealth Management
Colorado
$10K – – –
1
2 3

AMPE Hedge Fund Activity: Q3 2017 in Review

45 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2017, worth a combined $4.24M — down 6.7% from $4.55M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of AMPE and 4 opened new positions — a net loss of 10 holders — while 7 trimmed existing stakes and 7 added.

The largest buyer was United Capital Financial Advisors, opening a new position worth an estimated $8.07K. The largest seller was Legal & General Group, exiting entirely with an estimated $170K sold.

  • 45 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2017, down from 56 in Q2 2017.
  • Funds reported $4.24M of Ampio Pharmaceuticals Inc. stock for Q3 2017, down 6.7% quarter-over-quarter.
  • 4 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2017 and 14 closed out, a net change of -10 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q3 2017 was United Capital Financial Advisors, an estimated $8.07K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q3 2017 was Legal & General Group, an estimated $170K sold.

Based on aggregated 13F filings for Q3 2017.